+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cresemba"

Global Antifungal Drugs Market Size, Share & Trends Analysis Report by Drug Class (Azoles, Polyenes), Indication (Dermatophytosis, Aspergillosis), Dosage Form, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Global Antifungal Drugs Market Size, Share & Trends Analysis Report by Drug Class (Azoles, Polyenes), Indication (Dermatophytosis, Aspergillosis), Dosage Form, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • December 2023
  • 100 Pages
  • Global
From
Global Invasive Fungal Infections Market: Analysis By Molecule Class, By Infection Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 - Product Thumbnail Image

Global Invasive Fungal Infections Market: Analysis By Molecule Class, By Infection Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028

  • Report
  • May 2023
  • 143 Pages
  • Global
From
Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Thumbnail Image

Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • November 2023
  • 144 Pages
  • Global
From
Global Anti-Fungal Drugs Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Global Anti-Fungal Drugs Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 181 Pages
  • Global
From
Cresemba- Drug Insight, 2019 - Product Thumbnail Image

Cresemba- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 104 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Cresemba is a brand of antifungal medication used to treat certain types of fungal infections. It is used to treat infections caused by Aspergillus and Mucorales fungi, which can cause serious and life-threatening infections in people with weakened immune systems. Cresemba is a member of the azole class of antifungal drugs, which work by inhibiting the growth of fungi. It is available in both oral and intravenous formulations. The Cresemba market is a subset of the larger infectious diseases drugs market. It is composed of pharmaceutical companies that produce and market antifungal medications, such as Cresemba. These companies are focused on developing and commercializing treatments for fungal infections, which can be difficult to treat due to their resistance to many existing drugs. Some companies in the Cresemba market include Merck & Co., Pfizer, Astellas Pharma, and Novartis. Show Less Read more